Empowered Biologics Design & Development
Empowered Biologics Design & Development
Empowered Biologics Design & Development
At BioGlyph, we enable scientists to push the boundaries of what's possible with a format-agnostic platform that gives you control over biologics design and development from first thought to actionable structure.
At BioGlyph, we enable scientists to push the boundaries of what's possible with a format-agnostic platform that gives you control over biologics design and development from first thought to actionable structure.
INTRODUCING BIOGLYPH
A Universal Platform for Format-Agnostic Protein and Antibody Design
BENEFITS
Why BioGlyph?
Everything you need to collaborate, create in one place
One Platform, Endless Formats
Design any protein class, from monoclonals to complex multispecific antibodies, all within a consistent framework using proprietary standardized markup
One Platform, Endless Formats
Design any protein class, from monoclonals to complex multispecific antibodies, all within a consistent framework using proprietary standardized markup
One Platform, Endless Formats
Design any protein class, from monoclonals to complex multispecific antibodies, all within a consistent framework using proprietary standardized markup
AI Driven Design for MsAbs
Simulate molecular fitness in silico, prioritize candidates with the best developability profiles, and dramatically accelerate screening of large panels
AI Driven Design for MsAbs
Simulate molecular fitness in silico, prioritize candidates with the best developability profiles, and dramatically accelerate screening of large panels
AI Driven Design for MsAbs
Simulate molecular fitness in silico, prioritize candidates with the best developability profiles, and dramatically accelerate screening of large panels
Seamless Integration into Your R&D Ecosystem
Works natively with Geneious Prime, GraphPad Prism, and Protein Metrics — and adapts to the tools you already use
Seamless Integration into Your R&D Ecosystem
Works natively with Geneious Prime, GraphPad Prism, and Protein Metrics — and adapts to the tools you already use
Seamless Integration into Your R&D Ecosystem
Works natively with Geneious Prime, GraphPad Prism, and Protein Metrics — and adapts to the tools you already use
PRODUCTS
Core Features
Everything you need to collaborate, create, and scale, all in one place.
Design Pad (dPAD)
Panel Generation
2D Sequence Mapping
Variant Analyzer
Automated Detect Mass
Search by Structure
Universal Format & Molecule Registry
Design any Protein Format with Scientist-Grade Precision
Build the optimal drug format from custom building blocks; automatic backend registration keeps everything traceable.
Design Pad (dPAD)
Panel Generation
2D Sequence Mapping
Variant Analyzer
Automated Detect Mass
Search by Structure
Universal Format & Molecule Registry
Design any Protein Format with Scientist-Grade Precision
Build the optimal drug format from custom building blocks; automatic backend registration keeps everything traceable.
dPad
Design any Protein Format with Scientist-Grade Precision
Build the optimal drug format from custom building blocks; automatic backend registration keeps everything traceable.
Design Pad (dPAD)
Panel Generation
2D Sequence Mapping
Variant Analyzer
Automated Detect Mass
Search by Structure
Universal Format & Molecule Registry
Design any Protein Format with Scientist-Grade Precision
Build the optimal drug format from custom building blocks; automatic backend registration keeps everything traceable.
Designed for Tomorrow's Complex Therapeutics
Designed for Tomorrow's Complex Therapeutics
Built for Multispecific Antibodies
Built for Multispecific Antibodies
One of the fastest growing therapeutic modalities
One of the fastest growing therapeutic modalities
Designed to Manage Complex Modalities
Designed to Manage Complex Modalities
Including fusion proteins, bispecifics, and combinatorial biologics
Including fusion proteins, bispecifics, and combinatorial biologics
Developed by Protein Engineers, for Protein Engineers
Developed by Protein Engineers, for Protein Engineers
Our team is committed to improving the biologics workflow from day one
Our team is committed to improving the biologics workflow from day one
From Design to the Lab & Customer Benefits
From Design to the Lab & Customer Benefits
RESEARCH
What's Coming Next
MEET THE TEAM
Get to Know Us
Our Founders
Our Founders
Fernando Garces
CEO and Cofounder of BioGlyph, Inc
Fernando leads BioGlyph with a strong scientific vision and operational experience in translating antibody engineering innovations into practical R&D tools.
McClain Kressman
President and Cofounder of Bioglyph Inc.
McClain spearheads strategic partnerships and market expansion. His leadership ensures that BioGlyph delivers both scientific impact and commercial relevance.
Fernando Garces
CEO and Cofounder of BioGlyph, Inc
Fernando leads BioGlyph with a strong scientific vision and operational experience in translating antibody engineering innovations into practical R&D tools.
McClain Kressman
President and Cofounder of Bioglyph Inc.
McClain spearheads strategic partnerships and market expansion. His leadership ensures that BioGlyph delivers both scientific impact and commercial relevance.
Fernando Garces
CEO and Cofounder of BioGlyph, Inc
Fernando leads BioGlyph with a strong scientific vision and operational experience in translating antibody engineering innovations into practical R&D tools.
McClain Kressman
President and Cofounder of Bioglyph Inc.
McClain spearheads strategic partnerships and market expansion. His leadership ensures that BioGlyph delivers both scientific impact and commercial relevance.
Core Team
Core Team
Daniel Keri
Head of Protein Engineering
Daniel conceptualizes and designs high-thoughput, state-of-the-art workflows for in silico multispecific antibody assembly and analysis. He works with the software development team to bring these workflows to life.
Facundo Dartayete
Head of Software Engineering
Darta works side by side with protein engineers to together develop a first-in-class software that provides scientists with a powerful new tool box for working with biologics.
Daniel Keri
Head of Protein Engineering
Daniel conceptualizes and designs high-thoughput, state-of-the-art workflows for in silico multispecific antibody assembly and analysis. He works with the software development team to bring these workflows to life.
Facundo Dartayete
Head of Software Engineering
Darta works side by side with protein engineers to together develop a first-in-class software that provides scientists with a powerful new tool box for working with biologics.
Daniel Keri
Head of Protein Engineering
Daniel conceptualizes and designs high-thoughput, state-of-the-art workflows for in silico multispecific antibody assembly and analysis. He works with the software development team to bring these workflows to life.
Facundo Dartayete
Head of Software Engineering
Darta works side by side with protein engineers to together develop a first-in-class software that provides scientists with a powerful new tool box for working with biologics.
Sofia Begino
Software Developer Lead
Sofia contributes to our product’s development, from ideation and architecture to implementation. She focuses on building scalable, high-quality solutions that empower scientific progress.
Eliott Park
Computational Scientist and Engineering Lead
Eliott develops and applies computational methods, from molecular dynamics to AI, and drives new software features from concept to full-stack deployment.
Sofia Begino
Software Developer Lead
Sofia contributes to our product’s development, from ideation and architecture to implementation. She focuses on building scalable, high-quality solutions that empower scientific progress.
Eliott Park
Computational Scientist and Engineering Lead
Eliott develops and applies computational methods, from molecular dynamics to AI, and drives new software features from concept to full-stack deployment.
Sofia Begino
Software Developer Lead
Sofia contributes to our product’s development, from ideation and architecture to implementation. She focuses on building scalable, high-quality solutions that empower scientific progress.
Eliott Park
Computational Scientist and Engineering Lead
Eliott develops and applies computational methods, from molecular dynamics to AI, and drives new software features from concept to full-stack deployment.
Davide Blancone
Software Developer
Davide is a Full Stack Software Developer focusing on QA testing, test automation, and Jira board maintenance.
Davide Blancone
Software Developer
Davide is a Full Stack Software Developer focusing on QA testing, test automation, and Jira board maintenance.
Davide Blancone
Software Developer
Davide is a Full Stack Software Developer focusing on QA testing, test automation, and Jira board maintenance.
Scientific Advisory Board
Scientific Advisory Board
Sandeep Kumar
Scientific Advisor
Dr. Sandeep Kumar is the Co-founder and CTO of a stealth-mode TechBio startup, while also consulting in protein design and AI/ML–driven drug discovery. Until April 2025, he was a distinguished Fellow at Moderna, where he led molecular modeling and biodesign innovation.
Maria Gonzalez-Pajuelo
Scientific Advisor
Co-founder & Former CSO of FairJourney Biologics, Dr. Pajuelo is a driving force behind modern antibody discovery strategies. She has led development of Nanobody® platforms and engineered teams advancing over 100 therapeutic targets into clinical development.
Sandeep Kumar
Scientific Advisor
Dr. Sandeep Kumar is the Co-founder and CTO of a stealth-mode TechBio startup, while also consulting in protein design and AI/ML–driven drug discovery. Until April 2025, he was a distinguished Fellow at Moderna, where he led molecular modeling and biodesign innovation.
Maria Gonzalez-Pajuelo
Scientific Advisor
Co-founder & Former CSO of FairJourney Biologics, Dr. Pajuelo is a driving force behind modern antibody discovery strategies. She has led development of Nanobody® platforms and engineered teams advancing over 100 therapeutic targets into clinical development.
Sandeep Kumar
Scientific Advisor
Dr. Sandeep Kumar is the Co-founder and CTO of a stealth-mode TechBio startup, while also consulting in protein design and AI/ML–driven drug discovery. Until April 2025, he was a distinguished Fellow at Moderna, where he led molecular modeling and biodesign innovation.
Maria Gonzalez-Pajuelo
Scientific Advisor
Co-founder & Former CSO of FairJourney Biologics, Dr. Pajuelo is a driving force behind modern antibody discovery strategies. She has led development of Nanobody® platforms and engineered teams advancing over 100 therapeutic targets into clinical development.
Brian Webb
Tech Advisor
Brian Webb is a software engineer and entrepreneur with 25 years of experience in developing large-scale software systems. His expertise lies at the intersection of entrepreneurship and software technology innovation.
Brian Webb
Tech Advisor
Brian Webb is a software engineer and entrepreneur with 25 years of experience in developing large-scale software systems. His expertise lies at the intersection of entrepreneurship and software technology innovation.
Brian Webb
Tech Advisor
Brian Webb is a software engineer and entrepreneur with 25 years of experience in developing large-scale software systems. His expertise lies at the intersection of entrepreneurship and software technology innovation.
PRESS & MEDIA
Recent Highlights
Upcoming - Sept 18, 2025
Upcoming Webinar: Unprecidented Precision in Antibody Format Design with Dotmatics & BioGlyph
Join an exclusive webinar hosted by The Antibody Society, in collaboration with Dotmatics and BioGlyph, to explore how precision from sequence fidelity to integrated workflows can transform antibody R&D.
View On:
The Antibody Society
June 12, 2025
Dotmatics Launches BioGlyph Luma to Accelerate the Future of Protein Design & Engineering
As the newest addition to the Luma Scientific Intelligence Platform, BioGlyph Luma brings real-time traceability and design phase automation to the heart of R&D workflows.
View On:
Dotmatics
May 19, 2025
BioGlyph Featured at "From Models to Molecules: AI’s Expanding Roles in Therapeutics"
On May 19th, 2025, BioGlyph CEO and co-founder, Fernando Garces, spoke at "From Models to Molecules: AI's Expanding Roles in Therapeutics", hosted by Novoprotein Scientific Inc.
View On:
May 8, 2025
BioGlyph's First Happy Hour
BioGlyph's first event: “Unlock the Future of Biologics & Protein Engineering with BioGlyph Luma”—hosted by BioGlyph and Dotmatics at the symbolic Oyster Point in South SF, the birthplace of biotechnology.
View On:
February 27, 2025
BioGlyph CEO Featured in "Under the Surface Podcast"
"Under the Surface Podcast" hosts, Chris Williams and Dave Thompson have the pleasure of speaking to Fernando Garces, CEO and co-founder of BioGlyph.
View On:
Under the Surface Podcast
August 6, 2024
Dotmatics Announces Strategic Investment in BioGlyph
On August 6, 2024, Dotmatics announced a minority investment in BioGlyph to support development of its universal, format‑agnostic platform for designing, registering, and modeling multispecific antibodies.
View On:
Dotmatics
PRESS & MEDIA
Recent Highlights
Upcoming - Sept 18, 2025
Upcoming Webinar: Unprecidented Precision in Antibody Format Design with Dotmatics & BioGlyph
Join an exclusive webinar hosted by The Antibody Society, in collaboration with Dotmatics and BioGlyph, to explore how precision from sequence fidelity to integrated workflows can transform antibody R&D.
View On:
The Antibody Society
June 12, 2025
Dotmatics Launches BioGlyph Luma to Accelerate the Future of Protein Design & Engineering
As the newest addition to the Luma Scientific Intelligence Platform, BioGlyph Luma brings real-time traceability and design phase automation to the heart of R&D workflows.
View On:
Dotmatics
May 19, 2025
BioGlyph Featured at "From Models to Molecules: AI’s Expanding Roles in Therapeutics"
On May 19th, 2025, BioGlyph CEO and co-founder, Fernando Garces, spoke at "From Models to Molecules: AI's Expanding Roles in Therapeutics", hosted by Novoprotein Scientific Inc.
View On:
May 8, 2025
BioGlyph's First Happy Hour
BioGlyph's first event: “Unlock the Future of Biologics & Protein Engineering with BioGlyph Luma”—hosted by BioGlyph and Dotmatics at the symbolic Oyster Point in South SF, the birthplace of biotechnology.
View On:
PRESS & MEDIA
Recent Highlights
Upcoming - Sept 18, 2025
Upcoming Webinar: Unprecidented Precision in Antibody Format Design with Dotmatics & BioGlyph
Join an exclusive webinar hosted by The Antibody Society, in collaboration with Dotmatics and BioGlyph, to explore how precision from sequence fidelity to integrated workflows can transform antibody R&D.
View On:
The Antibody Society
June 12, 2025
Dotmatics Launches BioGlyph Luma to Accelerate the Future of Protein Design & Engineering
As the newest addition to the Luma Scientific Intelligence Platform, BioGlyph Luma brings real-time traceability and design phase automation to the heart of R&D workflows.
View On:
Dotmatics
May 19, 2025
BioGlyph Featured at "From Models to Molecules: AI’s Expanding Roles in Therapeutics"
On May 19th, 2025, BioGlyph CEO and co-founder, Fernando Garces, spoke at "From Models to Molecules: AI's Expanding Roles in Therapeutics", hosted by Novoprotein Scientific Inc.
View On:
Customers & Parnerships
Customer Benefits
Faster Design Cycles
Accelerate biologics design with greater precision and confidence.
Accelerate biologics design with greater precision and confidence.
Fewer Errors
Establish a single source of truth for sequence validation and final sequence generation.
Establish a single source of truth for sequence validation and final sequence generation.
Seamless Collaboration
Leverage a universal 2D format that makes protein designs easy to share, compare, and build upon.
Leverage a universal 2D format that makes protein designs easy to share, compare, and build upon.
Your Workflow, Your Way
BioGlyph is built to work with any LIMS system. Use it as a standalone solution or integrate it into your existing tools.
BioGlyph is built to work with any LIMS system. Use it as a standalone solution or integrate it into your existing tools.
Experience BioGlyph
Ready to Take the Next Step?
Request a personalized demo to explore how BioGlyph can transform your biologics workflows and accelerate discovery.
Contact Us
Experience BioGlyph
Ready to Take the Next Step?
Request a personalized demo to explore how BioGlyph can transform your biologics workflows and accelerate discovery.
Contact Us
Experience BioGlyph
Ready to Take the Next Step?
Request a personalized demo to explore how BioGlyph can transform your biologics workflows and accelerate discovery.
Contact Us